Where this LCD applies
Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.
Billing and coding article A57342: diagnoses and procedure codes
Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A57342 (Billing and Coding: Diagnostic and Therapeutic Colonoscopy) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.
Coverage is only half of the claim edit: when two of the listed procedure codes are billed on the same date, test the pair against the NCCI edits before relying on both being paid.
A57342: Billing and Coding: Diagnostic and Therapeutic Colonoscopy (Billing and Coding, effective 2025-11-06)
- Covered ICD-10-CM codes
- 273
- 1 group
- Non-covered ICD-10-CM codes
- 0
- Procedure codes listed
- 26
- Full article
- cms.gov record
| ICD-10-CM | Description (FY2027) |
|---|---|
| A04.3 | Enterohemorrhagic Escherichia coli infection |
| A04.5 | Campylobacter enteritis |
| A04.71 | Enterocolitis due to Clostridium difficile, recurrent |
| A04.72 | Enterocolitis due to Clostridium difficile, not specified as recurrent |
| A06.0 | Acute amebic dysentery |
| A06.1 | Chronic intestinal amebiasis |
| A06.2 | Amebic nondysenteric colitis |
| A06.9 | Amebiasis, unspecified |
| A18.31 | Tuberculous peritonitis |
| A18.32 | Tuberculous enteritis |
| A41.01 | Sepsis due to Methicillin susceptible Staphylococcus aureus |
| A41.02 | Sepsis due to Methicillin resistant Staphylococcus aureus |
| A41.4 | Sepsis due to anaerobes |
| A41.50 | Gram-negative sepsis, unspecified |
| A41.51 | Sepsis due to Escherichia coli [E. coli] |
| A41.52 | Sepsis due to Pseudomonas |
| A41.53 | Sepsis due to Serratia |
| A41.54 | Sepsis due to Acinetobacter baumannii |
| A41.59 | Other Gram-negative sepsis |
| A41.81 | Sepsis due to Enterococcus |
| A41.89 | Other specified sepsis |
| A42.7 | Actinomycotic sepsis |
| C18.0 | Malignant neoplasm of cecum |
| C18.1 | Malignant neoplasm of appendix |
Procedure codes: 44388, 44389, 44390, 44391, 44392, 44394, 44401, 44402, 44404, 44405, 44406, 44407, 45378, 45379, 45380, 45381, 45382, 45384, 45385, 45386, 45388, 45389, 45390, 45391, 45392, 45393.
Coverage indications, limitations and medical necessity
Colonoscopy is a visual examination of the lining of the large intestine using a rigid or flexible video or fiberoptic endoscope. The procedure includes inspection of the entire colon, from the rectum to the cecum, and may include the examination of the terminal ileum. A colonoscopy, by definition, must examine the colon proximal to the splenic flexure. The colonoscope is inserted via the anus or stoma, and then advanced under direct vision or video image. A rigid sigmoidoscope may be used for an intraoperative transcolotomy approach.
A colonoscopy requires the use of a flexible fiberoptic instrument that has the potential to examine the entire colon, and must potentially reach the entire colon (i.e. the cecum) when inserted through the anus.
Coverage for screening colonoscopy and other modalities for colorectal cancer is covered by CMS national policy NCD Chapter 1 Section 210.3 and in the Internet Only Manual 100-04, Chapter 18 Section 60.
A diagnostic colonoscopy is indicated for the following:
• Evaluation of an abnormality discovered by a radiology examination wherein the findings of the study are consistent with a colonic lesion that is likely to be clinically significant,
• An abnormal oncology colorectal screening or stool based DNA test as described in the CMS Colorectal Cancer screening Preventive Services requirements,
• Evaluation of unexplained gastrointestinal bleeding:
• Hematochezia that is not from the rectum or a perianal source,
• Melena of unknown origin after an upper GI source has been ruled out or when clinical findings indicate that a lower GI source may also be present,
• Presence of fecal occult blood, or
• Unexplained iron deficiency anemia.
• Clinically significant diarrhea of unexplained origin, after other appropriate workup,
• Evaluation of acute colonic ischemia/ischemic bowel disease,
• Evaluation of patients with streptococcus bovis endocarditis when a source is determined to likely to be of colonic origin (e.g. streptococcus bovis),
• Clinical suspicion of inflammatory bowel disease which may be manifested by abdominal pain, fever, diarrhea, bloody diarrhea, elevated erythrocyte sedimentation rate or other pertinent findings,
• Known chronic inflammatory bowel disease of the colon when a more precise determination of the extent of disease will influence clinical management,
• Surveillance of selected patients with Crohn’s colitis, or chronic ulcerative colitis for the purpose of ruling out colorectal cancer is considered high risk screening and should follow the requirements set forth in the CMS Internet Only Manual 100-04 Chapter 18 Section 60
• Surveillance of colonic neoplasia:
• Evaluation of the entire colon for a cancer with polyps noted on an earlier colonoscopy in accordance with the established national guidelines.
• This includes patients with known polyps from a previous colonoscopy or imaging study who have a known genetic predisposition for colon cancer.
• Intraoperative identification of the site of a lesion for findings that are suspected but that cannot be confirmed/detected by palpation or gross inspection at surgery.
Diagnostic colonoscopy is not covered for evaluation of the following:
• Chronic, stable irritable bowel syndrome,
• Acute limited diarrhea,
• Hemorrhoids,
• Metastatic adenocarcinoma of unknown primary site when a colonic origin is strongly suspected based on history and physical and imaging findings or biopsy reports,
• Routine follow-up of inflammatory bowel disease (except as indicated above in this section),
• Routine examination of the colon in patients about to undergo elective abdominal surgery for noncolonic disease,
• Upper GI bleeding or melena with a demonstrated upper GI source and absence of findings suggestive of a lower GI bleeding site,
• Bright red rectal bleeding in patients with a convincing anorectal source via direct examination, anoscopy, or sigmoidoscopy and no other symptoms suggestive of a more proximal bleeding source,
• Patients with a family history of colon cancer without a personal history of symptoms. These patients may be covered by the CMS Colorectal Screening coverage.
A therapeutic colonoscopy is indicated for:
• Treatment of bleeding from such lesions as vascular anomalies, ulceration, and neoplasia,
• Balloon dilation of a stenotic lesion,
• Decompression of a sigmoid volvulus and/or an acute non-toxic megacolon or pseudo-obstruction associated with Ogilvie’s Syndrome
• Removal of foreign body,
• Excision of colonic polyps.
• Repair of a perforation when it is expected that such repair will most likely avoid further surgical intervention and further surgical intervention is not needed (for example to drain an abscess at which time the perforation could be corrected by the surgeon)
Colonoscopy is contraindicated if the patient has:
• Fulminant colitis,
• Acute severe diverticulitis, or
• Suspected perforated viscus. A therapeutic colonoscopy by a trained endoscopist capable of repairing a perforation site may be allowed when the clinical findings and imaging studies strongly indicate that a perforation has occurred and the suspected site of the perforation allows for endoscopic repair.
Summary of evidence (opening)
NA
the full summary and analysis of evidence are in the CMS record.
Dates, lineage and related policies
- Original determination effective
- 2015-10-01
- Current revision effective
- 2025-11-06
- Last reviewed by the contractor
- 2021-03-02
- MCD version
- 56
- Derived from
- L33521
The contractor lists one National Coverage Determination as related: NCD 210.3 Colorectal Cancer Screening Tests. Where an NCD speaks, it controls; the LCD can only address what the NCD leaves open.
Other related documents: A55555 (Response to Comments), A55558 (Response to Comments).
Using this policy on a claim
Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the Noridian Healthcare Solutions, LLC hub lists every other active policy from the same contractor.
For teams evaluating QuickIntell software
Where QuickIntell fits with this policy
If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Frequently asked questions
What does LCD L34213 cover?
Colonoscopy is a visual examination of the lining of the large intestine using a rigid or flexible video or fiberoptic endoscope. The procedure includes inspection of the entire colon, from the rectum to the cecum, and may include the examination of the terminal ileum. A colonoscopy, by definition, must examine the colon proximal to the splenic flexure. The colonoscope is inserted via the anus or stoma, and then… The full 792-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.
Which states does LCD L34213 apply to?
Noridian Healthcare Solutions, LLC applies it to Medicare claims in 13 states plus 3 territories: AK, AS, AZ, CA, GU, HI, ID, MP, MT, ND, NV, OR, SD, UT, WA, WY. It binds only that contractor; outside these jurisdictions the same service is judged under the local contractor's own policy or, where none exists, claim by claim.
Which diagnosis codes support medical necessity under LCD L34213?
The companion billing and coding article A57342 lists 273 ICD-10-CM codes in 1 group that support medical necessity; the first 24 appear on this page, where the complete list opens by group with the contractor's group instructions.
How do I appeal a denial under LCD L34213?
A denial under LCD L34213 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A57342's 273 covered diagnosis codes, then file a redetermination with Noridian Healthcare Solutions, LLC within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- Medicare Coverage Database, current LCD exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file lcd.csvSHA-256 2e0eda3351aa3d47…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
- ICD-10-CM FY2027 code descriptionsVersion FY2027 · effective 2026-10-01 · file icd10cm_codes_2027.txtSHA-256 3c0583a38ee0e848…
Disclaimer
The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.